InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by 박창익, Chief Executive Officer. Insider active across 2 companies, notably 삼진제약. Aggregated, 2 reports have been logged. History available since 13 April 2026. The latest transaction was filed on 13 April 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
2 of 2 declarations
Park Chang-ik is the Executive Director at 삼진제약, a pharmaceutical company. In this role, he is responsible for managing operations and implementing the company's strategies. His leadership is essential for the development and growth of 삼진제약.